lung cancer
Conditions
Interventions
Single arm:Inject "vitamin C + arginine + magnesium sulfate" intravenously
Sponsors
Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Basic requirements for enrolled patients: 1. Lung cancer was diagnosed by pathology or cytology 2. According to the eighth edition of IASLC, the TNM staging of lung cancer is IV stage 3. Failure of multi-line therapy (third line or above) 4. The age is 18-80 years old, regardless of sex 5. The estimated survival time of the patients is no more than 3 months as assessed by 2 doctors with professional titles of deputy high school or above.
Exclusion criteria
Exclusion criteria: Exclusion criteria 1. Behavioral disorders with mental or cognitive impairment 2. Renal insufficiency or underlying kidney-related diseases 3. Liver insufficiency or underlying liver-related diseases 4. Allergic to vitamin C, arginine and magnesium sulfate 5. Complicated with the following diseases: hypermagnesemia, cysteinuria, gout, hyperoxaluria, uric acid nephrolithiasis, acidosis, diabetes, hemochromatosis, sideroblastic anemia, thalassemia, sickle cell anemia, myocardial damage, heart block, pulmonary edema, anuria 6. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment-related adverse events;; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival(OS);quality of life; | — |
Countries
CHINA
Contacts
Public ContactWenhui Li
Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University)
Outcome results
None listed